M

MeiraGTx Holdings plc

D
MGTX
USD
0.33
(5.1482%)
Market Closed
13,081.00
Volume
-2.25
EPS
-
Div Yield
-4.746479
P/E
520,221,420.38
Market Cap
Today
5.1482%
1 Week
21.881%
1 Month
63.911%
6 Months
25.746%
12 Months
31.128%
Year To Date
-3.989%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
M
MGNI
0.31
(2.3503%)
USD
M
MGIC
-0.02
(-0.186%)
USD
T
TTWO
12.75
(7.6586%)
USD
S
SABR
0.085
(2.4818%)
USD

Title:
MeiraGTx Holdings plc

Sector:
Healthcare
Industry:
Biotechnology
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.
Do you need help or have a question?
Contact Us